Skip to content
GLP-1 Desk
Menu
Dispatch #103

GoodRx

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

Visit GoodRxAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
Not disclosed
Tirzepatide
$299/mo (brand Zepbound)
Coverage
All 50 states
Brand-name
Yes

Line GoodRx up against its closest alternatives. Or go one-on-one: GoodRx vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency62/100
State access86/100
Molecule range71/100
Onboarding speed84/100
Support responsiveness64/100
Licensing & trust84/100

What the Desk likes

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where points come off

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves

The Desk's briefing — C

Best for: Readers who want self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies.

GoodRx ranks #103 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (19)

Pricing and verification reflect GoodRx's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on GoodRx's site. Not medical advice; see our disclosure.

← Back to The Desk